Ostéoporose chez les femmes ménopausées entre 40 et 65 ans : algorithme pour le gynécologue [Osteoporosis in menopausal women between 40 and 65 years old : an algorithm for the gynaecologist]

Détails

ID Serval
serval:BIB_68868F1117FE
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Titre
Ostéoporose chez les femmes ménopausées entre 40 et 65 ans : algorithme pour le gynécologue [Osteoporosis in menopausal women between 40 and 65 years old : an algorithm for the gynaecologist]
Périodique
Revue medicale suisse
Auteur(s)
Surbone A., Vulliemoz N., Gonzalez-Rodriguez E., Chatelain J.P., Lamy O.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Statut éditorial
Publié
Date de publication
26/10/2016
Peer-reviewed
Oui
Volume
12
Numéro
536
Pages
1811-1815
Langue
français
Notes
Publication types: Journal Article
Publication Status: ppublish
Résumé
Osteoporosis is a bone disease that promotes the development of fragility fractures. An algorithm is proposed for the gynaecologists'use to diagnose and treat osteoporosis in young menopausal women. The fracture risk can be calculated with the FRAX tool. If the 10-year fracture risk is ≥ 10 %, a bone densitometry is recommended, and the result is integrated in the FRAX tool. If the risk is between 10 and 20 %, a treatment should be discussed individually and, in some cases, a pharmacologic preventive treatment, by menopause hormonal treatment or SERMs, can be initiated. A pharmacologic treatment (bisphosphonates or dénosumab) is recommended in case of previous fragility fracture or risk ≥ 20 %, independently of a T-score < -2.5 DS. Patients have to be referred in case of treatment failure or intolerance, and at the end of any denosumab therapy.

Mots-clé
Adult, Aged, Algorithms, Bone Density Conservation Agents/therapeutic use, Denosumab/therapeutic use, Diphosphonates/therapeutic use, Female, Gynecology/methods, Humans, Menopause, Middle Aged, Osteoporosis, Postmenopausal/complications, Osteoporosis, Postmenopausal/drug therapy, Osteoporotic Fractures/prevention & control, Risk Assessment/methods
Pubmed
Création de la notice
03/08/2017 14:11
Dernière modification de la notice
07/10/2019 8:10
Données d'usage